What do we need to maximise the effect of drug-coated balloons? An Asian perspective. [PDF]
Muramatsu T.
europepmc +1 more source
Stent-less percutaneous coronary intervention using directional coronary atherectomy and drug-coated balloon angioplasty for a stenotic lesion in a patient with vasospastic angina. [PDF]
Sato K, Shinozaki M, Ikeda S, Takeda M.
europepmc +1 more source
Long-Term Efficacy of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent for De Novo Large-Vessel Coronary Arteries. [PDF]
Masuda M +6 more
europepmc +1 more source
One-Year Clinical Outcomes of Stentless Percutaneous Coronary Intervention Using Drug-Coated Balloon for True Bifurcation Lesions. [PDF]
Tanaka Y +7 more
europepmc +1 more source
Expanding the Role of Drug-Coated Balloons in Contemporary Percutaneous Coronary Intervention: Start of the Next Revolution or Just One More Weapon in a Growing Arsenal? [PDF]
Nathan S.
europepmc +1 more source
The future of sirolimus-coated balloon use in percutaneous coronary intervention. [PDF]
Yeh RW, Lalani C.
europepmc +1 more source
Successful prevention of medication-related osteonecrosis of the jaw after dental extractions by socket preservation with alloplast plus tetracycline in patients taking antiresorptive drugs. [PDF]
Lin LH, Wang CH, Lu SY.
europepmc +1 more source
Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model. [PDF]
Aihara K +9 more
europepmc +1 more source
Drug-Coated Balloons Versus Drug-Eluting Stents for Large Vessel Coronary Artery Disease: A Meta-Analysis. [PDF]
Zeng J +5 more
europepmc +1 more source

